Francine Grodstein to Neuropsychological Tests
This is a "connection" page, showing publications Francine Grodstein has written about Neuropsychological Tests.
Connection Strength
0.143
-
Anti-inflammatory agents and cognitive decline in a bi-racial population. Neuroepidemiology. 2008; 30(1):45-50.
Score: 0.055
-
Quantifying longitudinal cognitive resilience to Alzheimer's disease and other neuropathologies. Alzheimers Dement. 2022 11; 18(11):2252-2261.
Score: 0.036
-
GWAS for executive function and processing speed suggests involvement of the CADM2 gene. Mol Psychiatry. 2016 Feb; 21(2):189-197.
Score: 0.022
-
Reducing case ascertainment costs in U.S. population studies of Alzheimer's disease, dementia, and cognitive impairment-Part 2. Alzheimers Dement. 2011 Jan; 7(1):110-23.
Score: 0.017
-
Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology. Neurology. 2008 Jun 03; 70(23):2219-25.
Score: 0.014